A Medical Device Daily

Stem Cell Innovations (SCI; Houston/Leiden, the Netherlands) reported that it will collaborate with Massachusetts Eye and Ear Infirmary (MEEI; Boston) in a material transfer agreement using SCI’s human pluripotent stem cells, known as PluriCells.

MEEI, a leader in ophthalmology and otolaryngology research and a teaching partner of Harvard Medical School (Boston) will evaluate the ability of SCI’s PluriCells to form the human tissues implicated in hearing loss. In return SCI will receive a non-exclusive license to intellectual property generated using the PluriCells.

James Kelly, CEO of SCI, said, “As our PluriCells do not fall under the Presidential ban, there is a lot of interest from the academic world to get access to our human pluripotent stem cell platform.”

“Exploring the potential of PluriCells for our research is really exciting,” said Albert Edge of MEEI. “Until now, our research was hampered by a lack of good, quality human stem cells.”

SCI recently disclosed that it has produced multiple lines of human pluripotent stem cells that can be cultured in tissue culture plates without the use of feeder layers and then differentiated into multiple cell-types with the potential to aid in drug discovery and development. PluriCells are a type of pluripotent stem cell isolated from fetal tissue that can become all cell types of the body. Because they are developed from fetal germ cells, not viable embryos, they are eligible to be used in any National Institutes of Health -funded laboratory.

SCI said it is in the process of making its pluripotent cell lines widely available to universities and other not-for-profit institutions to rapidly advance stem cell research.

MEEI is a 42-bed specialty hospital focused on the treatment of difficult diseases of the eye, ear, nose, throat, head and neck.

In other agreements:

• Siemens Medical Solutions (Malvern, Pennsylvania) reported an alliance with Access e-forms which will provide healthcare organizations currently using Siemens’ Soarian HIM and Enterprise Document Management (EDM) solutions with new automated forms management capabilities.

Forms management, Access e-forms says, “is the ability to convert paper forms to online, electronic forms and generate forms on an ad hoc basis or automatically based on hospital-defined criteria.” Siemens says that it is focusing on delivering solutions that support the evolution to that paperless record.

Janet Dillione, president of the healthcare information technology division of Siemens, termed Soarian HIM “a key component of many Siemens customers’ electronic health record strategies. “We are pleased to collaborate with Access e-forms to extend this solution and expand our forms management offerings,” she added.

No Comments